DSGN vs GE · $214.0M cap vs P/E 44, rev $45.85B
Design Therapeutics Inc (DSGN) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
DSGN currently screens at market cap $214.0M. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the DSGN and GE stock pages for the full models.
Not investment advice.